In the clinic. Screening for colorectal cancer.

Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology (2015) 1.40

Results of the national lung cancer screening trial: where are we now? Thorac Surg Clin (2015) 0.77

Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk. Med Decis Making (2016) 0.75

Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17

Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16

Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med (2014) 2.89

Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc (2005) 2.63

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc (2009) 2.55

Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med (2012) 2.47

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst (2005) 2.27

Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06

Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96

Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96

Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94

Management of bleeding GI tumors. Gastrointest Endosc (2010) 1.79

Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care (2008) 1.75

Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol (2010) 1.69

Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res (2002) 1.65

The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol (2008) 1.61

Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer. Clin Cancer Res (2011) 1.59

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58

Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol (2008) 1.58

Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58

Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. Cancer Res (2012) 1.53

Retracted Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clin Cancer Res (2008) 1.51

Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap? Am J Gastroenterol (2011) 1.48

Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev (2006) 1.46

Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clin Gastroenterol Hepatol (2012) 1.44

PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest (2011) 1.43

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2008) 1.42

Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med (2009) 1.41

Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med (2009) 1.41

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) (2012) 1.39

Proteomic analyses of pancreatic cyst fluids. Pancreas (2009) 1.29

Developing a natural language processing application for measuring the quality of colonoscopy procedures. J Am Med Inform Assoc (2011) 1.28

Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol (2003) 1.28

Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2008) 1.27

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst (2012) 1.27

Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis. Proc Natl Acad Sci U S A (2010) 1.26

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. JAMA (2009) 1.21

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2004) 1.20

Diagnostic yield and clinical outcomes of capsule endoscopy. Gastrointest Endosc (2004) 1.17

Aberrant crypt foci: what we know and what we need to know. Clin Gastroenterol Hepatol (2007) 1.16

Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev (2007) 1.16

Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2004) 1.16

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc (2002) 1.16

Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol (2005) 1.13

Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol (2005) 1.13

Using the transtheoretical model to stage screening behavior for colorectal cancer. Health Educ Behav (2003) 1.11

A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol (2009) 1.08

Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res (2002) 1.08

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev Mol Diagn (2005) 1.07

Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res (2006) 1.06

Retracted Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Res (2007) 1.03

Using the interdependence model to understand spousal influence on colorectal cancer screening intentions: a structural equation model. Ann Behav Med (2012) 1.03

Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc (2011) 1.02

Beliefs about the causes of breast and colorectal cancer among women in the general population. Cancer Causes Control (2009) 1.00

Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.00

The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol (2007) 0.99

Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. J Cell Biochem (2003) 0.99

Build it, and will they come? Unexpected findings from a study on a Web-based intervention to improve colorectal cancer screening. J Health Commun (2011) 0.98

Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr Cancer (2008) 0.96

Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial. Am J Gastroenterol (2010) 0.96

Genome-wide search for gene-gene interactions in colorectal cancer. PLoS One (2012) 0.96

Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol (2013) 0.95

Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clin Gastroenterol Hepatol (2003) 0.95

Cancer in inflammatory bowel disease. An evidence-based analysis and guide for physicians and patients. Gastroenterol Clin North Am (2002) 0.95

Prevalence of adenocarcinoma at esophagectomy for Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol (2011) 0.94

Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr (2004) 0.93

Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol (2004) 0.92

Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut (2013) 0.92

Short- and long-term risk of colorectal adenoma recurrence among whites and blacks. Gastrointest Endosc (2013) 0.92

Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer (2002) 0.91

A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: trial design and baseline findings. Contemp Clin Trials (2010) 0.91

Molecular staging individualizing cancer management. J Surg Oncol (2012) 0.90

Design and utilization of the colorectal and pancreatic neoplasm virtual biorepository: An early detection research network initiative. J Pathol Inform (2010) 0.90

Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. Gastrointest Endosc (2009) 0.89

Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2005) 0.89

Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2011) 0.89

Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Opin Gastroenterol (2009) 0.88

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Int J Cancer (2011) 0.88

Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2007) 0.87

In the clinic. Colorectal cancer screening. Ann Intern Med (2008) 0.86

Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer. Mol Immunol (2009) 0.86

Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis (2007) 0.86

Association of physical activity and visceral adipose tissue in older women and men. Obes Res (2002) 0.86

Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing. Cancer Epidemiol Biomarkers Prev (2011) 0.85

Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 0.84

Genetic variants of adiponectin and risk of colorectal cancer. Int J Cancer (2014) 0.84

Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States). Cancer Causes Control (2002) 0.84

A qualitative analysis of couples' communication regarding colorectal cancer screening using the Interdependence Model. Patient Educ Couns (2011) 0.84

Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.84

Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps. J Cell Biochem (2004) 0.84

Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: a pilot study. Genet Med (2007) 0.83

Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia. Am J Hematol (2008) 0.83

Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer. J Surg Oncol (2012) 0.83

MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles. Epigenetics (2015) 0.82

Hemochromatosis gene mutations and distal adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev (2005) 0.82

Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer (2011) 0.81

GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients. Expert Rev Mol Diagn (2009) 0.80